Search results
Novartis Singapore. Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- Contact
Novartis Singapore Pte Ltd / Novartis Asia Pacific...
- Careers
Third Party Associate. Under Evaluation. Supporting...
- Products
Product Listing in Singapore. Below is a list of the...
- About
Learn more about Novartis, a global healthcare company based...
- Novartis in Singapore
Novartis Patient Declaration The Novartis Declaration for...
- News
Find contacts at Novartis for media and journalist inquiries...
- About Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. About Novartis
- Patients and caregivers Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.
- Healthcare professionals Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.
- Research and development Research & development Discover how Novartis turns breakthrough science into transformative, high-value treatments. Researchers
- ESG Environmental, social and governance Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.
- Investors Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.
- Contact
Third Party Associate. Under Evaluation. Supporting candidates during the Coronavirus pandemic (COVID-19) Novartis continues to monitor the Coronavirus situation with the safety of candidates, associates and patients as our primary concern.
Mar 15, 2024 · SINGAPORE - Swiss pharmaceutical giant Novartis is spending US$256 million (S$342.3 million) to expand its biopharmaceutical manufacturing plant here. The enlarged facility is expected to be...
Jun 3, 2024 · Novartis Singapore | LinkedIn. Pharmaceutical Manufacturing. View all 163 employees. About us. Novartis is reimagining medicine to improve and extend people’s lives. As a leading global...
Sep 28, 2021 · Singapore, September 28th, 2021 — Novartis announced the approval of Leqvio®(inclisiran) in Singapore for the treatment of adults with hypercholesterolemia (increased blood cholesterol level) or mixed dyslipidemia (unhealthy levels of one or more kinds of fat in the blood 7).
Mar 15, 2024 · In 2023, Novartis’ manufacturing facilities in Singapore shipped approximately 9 million treatment doses to patients around the world suffering from chronic hives and arthritis. Singapore is committed to working with like-minded partners towards common causes.
Apr 21, 2020 · Novartis Singapore has more than 1,000 associates working across divisions covering innovative medicines, generic and biosimilar medicines, the operation of two manufacturing plants, and its...
